Real-world use of osimertinib for epidermal growth factor receptor T790M-positive non-small cell lung cancer in Japan

OBJECTIVE: Adverse drug reactions (ADRs) during real-world osimertinib use were investigated in Japan. METHODS: Patients with epidermal growth factor receptor (EGFR) T790M-positive non-small cell lung cancer treated with second-line or later oral osimertinib per the Japanese package insert (80 mg on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohe, Yuichiro, Kato, Terufumi, Sakai, Fumikazu, Kusumoto, Masahiko, Endo, Masahiro, Saito, Yoshinobu, Baba, Tomohisa, Sata, Masafumi, Yamaguchi, Ou, Sakamoto, Kei, Sugeno, Masatoshi, Tamura, Reiko, Tokimoto, Toshimitsu, Shimizu, Wataru, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401719/
https://www.ncbi.nlm.nih.gov/pubmed/32548617
http://dx.doi.org/10.1093/jjco/hyaa067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401719/
https://www.ncbi.nlm.nih.gov/pubmed/32548617
http://dx.doi.org/10.1093/jjco/hyaa067

Ejemplares similares